Ageas’ H1 21 results are not what we would have expected. Asia’s Life business came in disappointing and Non-life is expected to be heavily impacted in the next quarter. But, overall, the outlook remains the same and the €150m share buy-back will cheer investors up. Tough times to go through but we remain positive in the medium term.
11 Aug 2021
Tough times, believed to be temporary
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Tough times, believed to be temporary
Ageas (AGS:EBR), 0 | ageas SA/NV (AGS:BRU), 0
- Published:
11 Aug 2021 -
Author:
Grégoire Hermann -
Pages:
2
Ageas’ H1 21 results are not what we would have expected. Asia’s Life business came in disappointing and Non-life is expected to be heavily impacted in the next quarter. But, overall, the outlook remains the same and the €150m share buy-back will cheer investors up. Tough times to go through but we remain positive in the medium term.